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Abstract: 
Psychostimulants like methylphenidate or D-amphetamine are often 
prescribed for attention deficit and hyperactivity disorders in children. 
Whether such drugs can be administered into a developing brain without 
consequences in adulthood is still an open question.  
Here, using in vivo extracellular electrophysiology in anesthetised 
preparations, combined with behavioural assays, we have examined the 
long-term consequences in adulthood of a chronic methylphenidate oral 
administration (5 mg/kg/day, 15 days) in early-adolescent (Post Natal 
Day  28) and late-adolescent (PND 42) rats, by evaluating body weight 
change, sucrose preference (indicator of anhedonia), locomotor sensitivity 
to D-amphetamine and electrical activities of ventral tegmental area (VTA) 
dopamine and dorsal raphe nucleus (DRN) serotonin neurons.  
Chronic methylphenidate treatment during early or late adolescence did 
not induce weight deficiencies and anhedonia-like behaviours at adulthood. 
However, it increased bursting activities of DRN serotonin neurons. 
Furthermore, chronic methylphenidate treatment during early but not 
during late adolescence enhanced D-amphetamine-induced rearing activity, 
as well as VTA dopamine cell excitability (firing, burst and population 
activity), associated with a partial desensitisation of dopamine D2 auto-
receptors.  
We have demonstrated here that early, but not late, adolescent exposure 
to oral methylphenidate may induce long-lasting effects on monoamine 
neurotransmission. The possible clinical implication of these data will be 
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Background Psychostimulants like methylphenidate or D-amphetamine are often 
prescribed for attention deficit and hyperactivity disorders in children. Whether such 
drugs can be administered into a developing brain without consequences in adulthood is 
still an open question.  
Methods Here, using in vivo extracellular electrophysiology in anesthetised 
preparations, combined with behavioural assays, we have examined the long-term 
consequences in adulthood of a chronic methylphenidate oral administration (5 
mg/kg/day, 15 days) in early-adolescent (Post Natal Day 28) and late-adolescent (PND 
42) rats, by evaluating body weight change, sucrose preference (indicator of anhedonia), 
locomotor sensitivity to D-amphetamine and electrical activities of ventral tegmental 
area (VTA) dopamine and dorsal raphe nucleus (DRN) serotonin neurons. 
Results Chronic methylphenidate treatment during early or late adolescence did not 
induce weight deficiencies and anhedonia-like behaviours at adulthood. However, it 
increased bursting activities of DRN serotonin neurons. Furthermore, chronic 
methylphenidate treatment during early but not during late adolescence enhanced D-
amphetamine-induced rearing activity, as well as VTA dopamine cell excitability 
(firing, burst and population activity), associated with a partial desensitisation of 
dopamine D2 auto-receptors.  
Conclusions We have demonstrated here that early, but not late, adolescent exposure to 
oral methylphenidate may induce long-lasting effects on monoamine neurotransmission. 
The possible clinical implication of these data will be discussed.   
 













































































Attention deficit hyperactivity disorder (ADHD) is a common psychological 
disturbance which affects an average of 5% of school-aged children worldwide (with 
very variable rate of prevalence ranging from 1 to 20%) (Polanczyk et al., 2015). It is 
characterised by inattention, impulsivity and hyperactivity. Currently available ADHD 
treatments include psychostimulants, such as D-amphetamine (D-AMP) and 
methylphenidate (MPH), which when administered at the adequate dose, have a 
powerful and immediate therapeutic effect. However, as indirect dopamine agonists, 
they also have the potential to affect the motor system and disrupt dopamine-dependent 
behaviours (Volkow and Swanson, 2003). One of the other alarming points is the large 
increase rates of ADHD diagnosis and prescription of medications over the last years 
which do not represent the rates of true prevalence of the disorder, likely caused by a 
lack of consistency of strict diagnostic criteria (Polanczyk et al., 2014). This has pointed 
out the fact that the drug may be inadequately administered to non-ADHD children. 
 
Though ADHD occurs mainly during childhood and adolescence (Adesman, 2001, 
Hurtig et al., 2007, Wilens and Spencer, 2010) it can persist throughout the entire adult 
lifespan in a widely ranged proportion of patients (ten to sixty percent), depending on 
the different cohorts, if previously diagnosed with childhood ADHD (Kessler et al., 
2005, Gentile et al., 2006, Pehlivanidis, 2012). Evidence for long-term side effects of 
psychostimulants is limited. Exposure to psychostimulant drugs on a developing brain 
may not be without risk, knowing that previous exposure with drugs that have abuse 
potential can later induce drug-taking and drug-seeking behaviours (Bartoletti et al., 
1987, Gubellini et al., 1990, Gaiardi et al., 1991, Shippenberg et al., 1996).  
Adolescent exposure to MPH may be associated with altered emotional responses and 
anxiety-like behaviour in adulthood (Bolanos et al., 2003), increased impulsiveness 
(Pardey et al., 2012), impaired learning (Rowan et al., 2015) and impaired reproductive 
axis (Fazelipour et al., 2012). On the positive side, other studies found that chronic 
MPH can have persistent beneficial effect on prefrontal cortex plasticity and cognition 
(Burgos et al., 2015). Though childhood or adolescent exposure to MPH to rats at 
moderate (Brandon et al., 2001, Crawford et al., 2007, Crawford et al., 2011) to high 


































































doses (Achat-Mendes et al., 2003, Halladay et al., 2009) may enhance response to drug 
of abuse, other studies have consistently demonstrated that low doses can induce an 
attenuated cocaine-induced conditioned place preference, a measure of the incentive 
properties of a given drug (Carlezon et al., 2003, Augustyniak et al., 2006, Brenhouse et 
al., 2009). In contrast, a recent study on ADHD genetic model (spontaneous 
hypertensive rats) suggests that initiation of methylphenidate treatment in adolescence 
may increase cocaine abuse risk (Jordan et al., 2014).  
 
Chronic methylphenidate administration may cause persistent alterations in the 
electrical characteristics of midbrain monoaminergic neurons, potentially causing 
changes in behavioural functions related to emotion, drug addiction or even cognition. 
Interestingly, only a few studies have attempted to examine in parallel putative changes 
in electrophysiological activity and alteration in behavioural function. Two 
electrophysiological studies reported persistent effects, but in different directions, on 
dopamine neuronal activity of low doses of MPH (1-2 mg/kg) administered 
subchronically and intraperitoneally to adolescent rats (1-2 mg/day, 1-3 weeks), and no 
difference in dopamine autoreceptor sensitivity (Brandon and Steiner, 2003, Shen and 
Choong, 2006). To our knowledge, no studies have investigated the effect of a juvenile 
chronic MPH treatment on serotonin neurotransmission. This would be of particular 
interest as some behavioural studies have shown that chronic juvenile methylphenidate 
administration at moderate (Bolanos et al., 2003; Carlezon et al., 2003) or high dose 
(Brookshire and Jones, 2012) can induce depressive-like behaviour and increase 
sensitivity to stress (Bolanos et al., 2003, Brookshire and Jones, 2012), which may be 
more specifically related to deficits in serotonin neurotransmission.  
 
The large discrepancy of results in literature may be attributed to differences in doses, 
length of treatment and washout period, as well as route of administration. There are 
also disputes about the validity of the doses administered, whether within or over the 
therapeutic range. Most studies have examined the effects of systemic psychostimulant 
administration, which is not a reflection of the clinical situation where the drug is 
usually administered orally. Though methylphenidate has a relatively short half-life (3-4 
hr) and low bioavailability (20-40%), it is more slowly absorbed if orally administered, 


































































particularly in drinking water (Wargin et al., 1983, Thanos et al., 2015). Therefore, the 
total exposure time to the drug may be fundamentally different whether the drug is 
administered orally or systemically. Oral administration, particularly in drinking water 
during the dark period should help to maintain plasma concentrations for a longer 
period, and is therefore more clinically relevant, mimicking to some extents extended 
release formulations (Thanos et al., 2015). This may impact on the long-term effect of 
the drug on the different neurotransmitter systems.  
 
In the present study, we have compared the possible long-term consequences of a 
chronic oral methylphenidate administration on growth, serotonin and dopamine 
neurotransmission in two age groups of animals: early adolescents (Post Natal Day 28) 
and late adolescents (PND 42). We have also attempted to characterise a possible link 
between putative changes in behaviours and electrical characteristics of serotonin and 
dopamine neurons and dopamine autoreceptor sensitivity. To this end we have 
combined our electrophysiological investigation with assessments of the motor response 
to D-amphetamine and of the sucrose preference test, which can assess putative 
anhedonic behaviour. In addition, in some of our experiments, we have also compared 
administering MPH as oral daily administration (twice a day, diluted in a sucrose 
solution) to continuous overnight administration in drinking water. These two 




Material and Methods 
 
A- Subjects and groups 
 
 Male Sprague-Dawley rats were purchased from Charles River, UK. Animals were 
housed in groups of 2-4 per cage, maintained at 20-22
o
C with humidity rates above 40% 
under a 12:12 L/D cycle with lights ON at 07h00. Food and water were provided ad 
libitum. Animals were allowed a 3-day acclimatisation period after delivery. All 
experiments were performed during the light phase and with permission from the UK 


































































Home Office and De Montfort University Ethics Committee. During treatment animals 
were weighted every other day and concentration of MPH in the sucrose solution or 
drinking water for oral administration was readjusted in order to administer a consistent 
dose of 5 mg/kg/day per animal. For administration of MPH in the drinking water the 
daily amount of fluid consumed per animals was also measured in order to evaluate the 
adequate concentration of MPH in the drinking bottle. 
All animals were kept 2-3 per cage and split into the following groups. 
-Naïve animals, kept in standard laboratory conditions for the same period as the treated 
ones (n=22). 
-Early adolescent (weight 70-80 g, Post Natal Day (PND) 28, n=22) or late adolescent 
(150-180 g, PND 42, n=24) animals which were administered MPH (5 mg/kg/day) in a 
2 ml/kg 10% (w/v) sucrose solution, twice a day (2x2.5 mg/kg, 0.5 ml volume intake), 
for 15 consecutive days, followed by a washout period.  
-Early adolescent (n=8) or late adolescent animals (n=7) treated with 5 mg/kg/day of 
MPH incorporated in the drinking water during the dark phase (removed/replaced by 
water-containing bottles at the beginning of the light phase). Animals of this group were 
kept 2 per cage and had very similar weight (+/- 5%) within cage. It was also 
established from preliminary experiments that animals drank very similar amount of 
water in proportion to their weight, with very little inter-individual variations. In 
addition, tested and control animals drank the same amount of fluid per day.  
Oral administration of 5 mg/kg of MPH by these two methods should not produce 
plasma peak of MPH concentration higher than the clinical range defined as 8-40 ng/ml 
(Berridge et al., 2006, Thanos et al., 2015).  
Treatments lasted 15 days, followed by a 28-35-day washout period. We paid attention 
to the fact that animals from all groups, including naïve animals, should have relatively 
similar weight/age, ranging from 360-460 grams, when tested for 
electrophysiology/behaviour at a time they were young adults (PND>65). For this 
reason, late adolescent-treated animals have generally been investigated after a shorter 
washout period (average 10 days) than the early adolescent-treated rats to keep them 


































































with a similar weight at the time of our electrophysiological and behavioural 
investigations. However, we also studied a group of late adolescent-treated animals 
(n=8) with a longer washout (2-3 weeks) and found that the length of the washout 
period had no impact on electrophysiological and behavioural parameters in these pre-
adult-treated animals.  
 
B- Sucrose preference test 
 
After at least 10 days following the last MPH or sucrose administration during early or 
late adolescence, some animals (n=24) were subjected to a sucrose preference test, 
adapted from previous published protocols (Overstreet, 2012, Mateus-Pinheiro et al., 
2014, Li et al., 2015, Mileva and Bielajew, 2015, Tang et al., 2015). Briefly, rats were 
tested for sucrose preference over a four-day period using a two-bottle choice test. 
Animals had ad libitum access to food and water throughout the experiment. On the first 
day, rats were housed singly and accustomed to drinking from two water bottles. On the 
following three days, rats were trained on the sucrose preference test, in which one out 
of the two water bottles was replaced with a bottle containing a 2% sucrose solution 
(w/v). Rats were allowed to drink freely from both bottles during the 12-hour nocturnal 
phase. At the beginning of the light phase, both bottles were replaced by bottles 
containing water only. The bottles were weighed and refilled each day at the same time 
in the morning. The positions of the bottles were switched daily to avoid position 
preferences which have been observed in mice (Bachmanov et al., 2002). Sucrose 
preference was determined as the quotient of sucrose consumption to the total liquid 
intake over a definite period (Day 1, 2, 3, 4 or average Day 2-4), consisting of both 
water and sucrose intakes. A sucrose preference score lower than 65% was considered a 
depressive-like phenotype (Willner, 1997, Strekalova et al., 2004, Briones et al., 2012a, 
Couch et al., 2013). 
 
 
C- D-amphetamine-induced locomotor activity 
 


































































At least 20 days following the last MPH administration, some rats (n=21) were housed 
individually for the behavioural experiments. All drugs were dissolved into saline. 
Animals received a single intraperitoneal injection of either: 0.8 ml/kg of saline, or 1 
mg/kg of D-amphetamine in saline. Animals were then scored for behavioural 
parameters during 15-minute time periods and up to a total of 60 minutes following the 
injection. Counting of well-defined behavioural traits such as rearing, scratching, 
grooming, jumping, running, climbing, catalepsy and stereotypical movements were 
done manually. Drugs or saline were injected approximately 30 min after the rat was put 
in the individual testing cage and the observation period started 2 minutes after 
administration. Saline administration was carried out in a group of 4 animals from both 
naïve and early-adolescent treated animals. At the end of the assessment, animals return 
to their original cage.  
 
D- In vivo extracellular single unit electrophysiology  
1-General recording procedures:  
Animals were anaesthetised with chloral hydrate (400 mg/kg, with additional doses 
administered if necessary), secured to a stereotaxic frame and maintained at 36–37 °C 
with a heating pad. An incision was made across the top of the head and the edges of the 
skin drawn back to reveal the cranium. Bregma was marked and a hole was drilled 
through the bone at the coordinates of the region of interest to the atlas of Paxinos and 
Watson (1997). 
Electrodes were manufactured in house from borosilicate capillaries (1.5 mm, Harvard 
Apparatus Ltd., UK) pulled on a PP- 830 electrode puller (Narishige, Japan) and filled 
by hand with an electrolyte solution (in mM: NaCl 147, KCl 4, adjusted to pH 6). The 
tip of the electrode was broken down under a microscope to an external diameter of 1–
1.5 µm. Typical resistance was in the range 4–8 MΩ. Outputs from the electrode were 
sent to a Neurolog AC pre-amplifier and amplifier (Digitimer, UK). Signals were 
filtered and sent to an audio amplifier, a Tektronix 2201 digital storage oscilloscope, 
and a 1401 interface connected to a computer running Spike 2 (CED, Cambridge, UK) 
for data capture and analysis. Descent of the electrode was carried out using a hydraulic 
micromanipulator (Narishige). Typically, a minimum of 7 cells were recorded per 


































































animal (particularly for measuring average electrophysiological parameters). No more 
than 10 electrode descents were performed per animal. 
 
2- Serotonin neurons  
Only putative serotonin neurons with a large and long-lasting triphasic extracellular 
potential (1-2 ms), a low but regular firing activity (1-40 spikes per 10 seconds) were 
recorded (Vandermaelen and Aghajanian, 1983, Urbain et al., 2006, Oosterhof et al., 
2015). To further confirm the specific recording of serotonergic neurons, systemic 
exposure to 8-OH-DPAT (5-Hydroxy-N,N-dipropyl-2-aminotetralin) was performed at 
the end of some recordings, which induced neuronal silencing that could be reversed by 
WAY-100135 administration. Bursting of DRN serotonin neurons was calculated with 
the following criteria: at least two bursts occurring within 20 ms or less and followed by 
a silence period of at least 40 ms, adapted from previous electrophysiological 
investigations (Labonte et al., 2012; Manta, Dong, Debonnel, & Blier, 2009; Rouchet et 
al., 2008). The number of putative DRN serotonin neurons per track was recorded by 
recording the total number of active serotonin neurons encountered during one electrode 
descent within the DRN, at the following coordinates: anteroposterior -7.5 to -8 mm to 
Bregma, lateral 0 mm, dorsoventral 5-7 mm below cortical surface.  
 
3- Dopamine neurons 
Midbrain dopamine neurons were identified according to criteria summarised by 
Ungless and Grace (Ungless and Grace, 2012). Presumed dopaminergic neurons 
displayed typical characteristics such as: a triphasic action potential lasting 2.5-3.5 ms 
often with a notch in the rising phase, a prominent negative compound and a time 
greater than 1 ms from the start of the depolarisation to the end of the repolarisation, a 
relatively low firing activity between 5-90 spikes/10 s with occasional bursting pattern. 
A burst activity in such neurons is defined as two spikes occurring at an interval of 80 
ms or less, followed by a silence period of at least 160 ms. Coordinates for the ventral 
tegmental area were: anteroposterior -4.5 to -5.7 mm to Bregma, lateral 0.3-1.2 mm, 
7.2-9.5 mm below cortical surface. 
 
E- Data analysis 


































































Results are expressed as the mean±standard error of the mean (SEM). Statistical 
comparisons were carried out using either, as appropriate, one-way analysis of variance 
(ANOVA) followed by Newman-Keuls tests or two-way ANOVA followed by 
Bonferroni post hoc analysis. Statistical significance was considered if p<0.05. 
For behavioural experiments, the sum of each behavioural trait occurring during 15-
minute interval periods was considered.  
The mean basal firing activity was evaluated after the neuron had attained a stable firing 
rate, generally after at least 5 min of recording. In case of drug administration: pre-drug 
values of firing rate were obtained by averaging the firing rate over a period of at least 2 
min immediately prior to the intravenous administration of the drug, while post-drug 
values were obtained by averaging the firing over a period of 4 min following drug 
administration. Proportions of a specific type of response in two different groups of 
animals were also compared using the Fisher’s exact or Chi-squared test (comparing 




A- Adolescent treatment with methylphenidate does not induce growth deficits 
 
The impact of a chronic methylphenidate treatment during adolescence on growth 
parameters was investigated. We noted with interest that MPH, administered orally at 5 
mg/kg/day and for 15 days (in drinking water or via a sucrose solution), did not induce 
any body weight gain deficiency during the treatment period (not shown). After the 
washout period, no differences were observed between MPH-treated animals and 
vehicle-treated animals. In another study, we found the same absence of effect after 15 
days of intraperitoneal MPH administration (4 mg/kg/day), though more individual 
variations were noted (Di Miceli and Gronier, 2014). 
 
 
B- Sucrose preference test 
 


































































This test was performed in early (8 MPH treated and 4 controls) and late adolescent-
treated (8 MPH treated and 4 controls) animals which were administered sucrose only 
or MPH in a sucrose solution (10 %) twice daily (2.5 mg/kg x 2). At the end of the 
washout period (at least 8 days after the last administration), animals were assessed for 
the sucrose preference-test. Using a protocol that evaluates sucrose preference in basal 
condition (non-water-deprived, see Briones et al., 2012b), we found that animals 
successfully learnt to discriminate water from sucrose. Indeed, the transition from the 
first day to the second day is marked by an increase in liquid consumption (Fig. 1A) 
found in 11 out of 12 animals (92%) from the early-adolescence group and 12 out of 12 
from the late-adolescence group. Interestingly, after this initial increase in sucrose 
consumption, animals tend to decrease their sucrose consumption on the third day to 
finally maintain this level of consumption the following days (Fig. 1A). MPH-treated 
animals and sucrose only-treated animals did not differ in their sucrose preferences (Fig. 
1B-C), in both early and late adolescence-treated groups. The low scores, observed in 
25% of early-adolescence-treated animals, were not due to individual decreases in total 
volume intake, as both control and tested groups displayed similar liquid intake patterns 
(Fig. 1A). We use the 65% threshold to discriminate anhedonic-like behaviours 
(Willner, 1997, Strekalova et al., 2004, Briones et al., 2012b, Couch et al., 2013). 
Therefore MPH treatment did not induce any long-term anhedonia traits in rats, whether 
early adolescence or late adolescence-treated. This experiment was reproduced in naive 
animals (n=10) and the same low frequency of this phenotype was observed (10%, Fig. 
1D), indicating that previous sucrose intake (during the chronic MPH administration) 
has no impact on sucrose preference.  
C- D-amphetamine-induced locomotor activity 
 
When D-amphetamine is administered intraperitoneally (>1 mg/kg) to naive adult rats, 
it induces considerable rearing activities in the first hour following the administration. 
In general, no rearing events were recorded during the last 15 min before administration 
of the drug. On the other hand, administration of saline only marginally caused rearing 
events in both control or tested animals (not shown).  


































































In the present study, we used a low dose of D-amphetamine (1 mg/kg) which induces 
peak rearing events activity during the first 30 minutes of observation. This was 
followed by progressive time-dependent decreases of such events, in both control and 
tested groups (Fig. 2). In both groups of control animals (sucrose-treated, n=8, or naïve 
rats, n=12) similar changes in rearing activity was observed over the time course of the 
experiments (average number of rearing events, sucrose/naive: 18/23, 41/35, 39/38, 
35/21 for 0-15, 15-30, 30-45 and 45-60 min, respectively). Likewise, animals treated 
with MPH, either administered in sucrose solution (n=7) or in drinking water (n=8), 
displayed similar changes in rearing activity following the D-amphetamine challenge 
(average number of rearing events, sucrose/drinking water: 49/41, 60/47, 43/36, 46/35 
for 0-15, 15-30, 30-45 and 45-60 min, respectively). The number of rearing activity was 
slightly higher in the sucrose group, but this was not statistically significant due to large 
individual variation (p<0.4, unpaired Student’s test, 15-30 min). Data from both control 
groups and from both treated groups were therefore pooled. Overall, we observed that 
animals previously treated orally with MPH during early adolescence (5 mg/kg/day) 
displayed significantly more frequent rearing events during the first 15 minutes of 
observation (Fig. 2). The two-way ANOVA analysis of average rearing activity shows a 
significant effect of treatment (F1,132=7.99, p<0.005), which is attributed to an increase 
in rearing activity in the group of animals pre-treated with MPH during early 
adolescence for the first 15 min following the D-AMP challenge (p<0.05), compared to 
control rats. The number of rearing/vertical events tend to remain higher during the 15-
30 min periods in the tested groups, but this was not statistically significant, (p<0.09, 
unpaired Student’s t test). On the other hand, the proportion of rats that displayed high 
rearing activity (arbitrarily defined as >10 events during each 15-min test period) was 
significantly higher in the treated group than in the control group during the 0-15 min 
period (12/15 versus 8/20, p<0.04, Fisher exact test) and during the 15-30 min period 
(11/15 versus 8/20, p<0.04). 
Interestingly, this increase in rearing activity observed during the first 15 min following 
the administration of D-AMP was not observed in a group of 6 rats that were previously 
orally treated with MPH during post adolescence (following at least a 10-day washout 
period). These rats show similar behavioural activation than the control rats and 


































































significantly lower rearing activity than the early adolescence MPH-treated animals 
(Fig. 2). 
All of the other behavioural events (scratching, grooming, jumping, running, climbing, 
catalepsy, stereotypical movements), which were occasionally triggered by D-AMP, did 




D- Adolescent MPH leads to long-term adaptations in serotonin neurons in 
adulthood 
 
Three to five days following the sucrose preference test, serotonin neurons from the 
dorsal raphe nucleus (DRN) were examined in vivo in some animals (n=23). Typically, 
at least 7 neurons were studied per animal. MPH, administered orally at 2.5 mg/kg twice 
a day for 15 consecutive days during early adolescence (n=12), did not change the firing 
activity of DRN serotonin neurons compared to rats treated with sucrose only during 
early adolescence (Table 1). However, it significantly increased (p<0.007, Student’s t-
test) burst discharges in these neurons by 4-fold (Fig. 3B). In this group, 26% of the 
neurons tested (13/50) displayed bursting activities whereas only 12% did so in 
respective control group (8/65, p<0.05, Fisher test). In rats administered MPH in late 
adolescence (n=11), no significant changes of the electrophysiological properties of 5-
HT neurons were found at adulthood, when compared to rats treated with sucrose only 
during late adolescence (Table 1). Figure 3A-C shows that burst activity, but not firing 
activity nor population activity, of serotonin neurons is significantly higher in the early 
adolescence MPH-treated group than in all control animals (early and late adolescent 
sucrose-treated animals grouped together).  
Interestingly, in the early adolescence MPH-treated animals (n=7), we found a negative 
correlation between sucrose preference results and average burst activity of 5-HT 
neurons (Fig. 3D), but not with the other firing parameters (not shown). In control 
animals (sucrose solution only) and in late adolescence MPH-treated animals, we did 
not observe such correlation, probably due to the fact that average bursting activities per 
animal were lower.  



































































E- Adolescent MPH leads to long-term adaptations in midbrain dopamine 
neurons in adulthood 
 
Control animals (n=4) that were orally administered the sucrose solution during 
adolescence displayed similar firing and burst activities of ventral tegmental area (VTA) 
dopaminergic neurons than untreated control animals (n=5; Table 1). VTA dopamine 
neuron firing and burst activities from both groups of animals exposed to MPH during 
early adolescence (in sucrose solution, n=4, or in drinking water, n=6) did not differ 
significantly (Table 1). Firing activities tend to be higher in the two groups of rats 
treated during adolescence, compared to their respective control groups but the 
differences were not statistically significant. On the other hand, previous exposure to 
MPH during early adolescence consistently increased baseline burst activities in each 
subgroup of orally treated rats compared to respective controls; this effect was 
significant in the group of rats administered MPH in drinking water (unpaired t-test, 
p<0.03).  
Dopamine cells from late adolescence MPH-treated animals had also similar firing and 
burst activity whether MPH was administered in sucrose solution (n=8) or drinking 
water (n=4) and have very similar values than rats administered sucrose during late 
adolescence (n=9) or untreated control animals (n=5) (Table 1). In both groups of 
animals exposed to MPH during late adolescence, burst activity of VTA dopamine 
neurons was lower than in the corresponding early adolescent groups exposed to MPH, 
but this was significant only in the group where MPH was administered in drinking 
water (p<0.03, unpaired Student t test, Table 1). 
We then pooled the animals into three groups: rats previously treated orally with MPH 
(whether in sucrose solution or in drinking water) during early adolescence, rats 
previously treated orally with MPH during late adolescence and control rats (whether 
sucrose-treated or age and weight matched naive). We found that electrophysiological 
characteristics of VTA dopamine neurons were affected by chronic oral MPH treatment 
during early adolescence. Both firing and burst activities were significantly higher in the 
group of rats previously exposed with MPH during early adolescence, compared to 
controls and to rats treated during late adolescence (Fig 4). We also found that 


































































population activity (expressed as the number of spontaneously discharging dopamine 
neurons encountered per electrode descent) was also significantly increased in rats 
treated with MPH orally as early adolescents, compared to the other groups (Fig. 4). 
 
F- Adolescent MPH exposure induces partial dopamine D2 receptor 
desensitisation in adulthood 
In these experiments, we combined data from animals that were orally administered 
MPH in sucrose solution or in drinking water, as well as from all control animals 
(subsequent analysis of our data did not show any differences in response to dopamine 
receptor agonists between different subgroups). Using a wide range of apomorphine (a 
D2 receptor agonist) doses intravenously administered, with progressive 10 µg/kg 
increments and up to a cumulative dose of 50 µg/kg (or 70 µg/kg in some animals), 
animals previously exposed to MPH during early adolescence displayed a significant 
shift in their sensitivity to the D2 agonist, as seen in Fig. 5A-B. Analysis indicates a 
significant dose (F5,68=12, p<0.0001) and treatment effect (F1,68=24; p<0.0001) with no 
significant interaction (F1,68=1.8; p<0.13). Treatment effect was attributable to a 
significantly higher firing rate in MPH-treated rats at the dose of 10, 20 and 30 µg/kg of 
apomorphine (Fig. 5A). Equivalent results were obtained when % of firing decreases 
from baseline were considered (Fig. 5B). Figure 5A-B also shows that the depressing 
effect of apomorphine on the firing rate was reversed by the D2 antagonist eticlopride. 
Figure 5C shows representative firing rate histograms and burst train of a VTA 
dopamine neuron from an early adolescence MPH-treated rat during administration of 
cumulative doses of apomorphine, which displayed such partial insensitivity to the 
agonist. 
This prompted us to carry out another study on dopamine D2 autoreceptor sensitivity to 
compare MPH-treated animals in early and late adolescence, using quinpirole (a more 
selective D2 receptor agonist). Intravenous administration of quinpirole (20 µg/kg) led 
to strong and reversible (following eticlopride injection) firing rate reductions of VTA 
dopamine neurons (Fig. 6A-B). Dopamine neurons from animals exposed to MPH 
during early adolescence displayed lower sensitivities (assessed as the percentage of 
decrease in the firing rate) to the dopamine D2 receptor agonist (78, 45 and 75% for 
controls, early and late adolescent MPH-treated groups, respectively, F2,23=3.64, 


































































p<0.04, Fig. 6B). As indicated in the figure, there is a significantly lower effect of 
quinpirole on dopamine neurons from rats initially treated with MPH during early 
adolescence compared to animals treated lately and control rats (p<0.05, Newman-Keul 
test). The proportion of neurons completely or nearly completely silenced (firing<5 
spikes/10 s) by quinpirole was significantly different in the three subgroups (6/11, 0/7, 
4/7 neurons from the control, early adolescent-treated and late adolescent-treated 





Our results, showing that adolescent exposure to MPH does not induce growth velocity 
deficits corroborate previous observations (Pizzi et al., 1987, Achat-Mendes et al., 2003, 
Spencer et al., 2006). 
In adult rodents, adolescent exposure to high (Brookshire and Jones, 2012, 
Motaghinejad et al., 2015) or the apeutic (Carlezon et al., 2003, Bolanos et al., 2003) 
dosing of MPH has been associated with depressive-like effects, at least based on 
increased immobility in the forced swim test in rats when tested during adulthood; 
though this was not always observed (van der Marel et al., 2015). Our study supports 
the assumption that early or late adolescence MPH administrations did not induce more 
anhedonic-like behaviour in adulthood (Fig. 1) than what is generally found in the 
background population. Interestingly, we showed that some control animals (n=2) and 
one early adolescence MPH treated animal display sucrose preferences below 65%. This 
stands in contrast to other investigations using the same protocol and strain of animals 
showing sucrose preference above 70% on all control rats (Wang et al., 2014, Boyko et 
al., 2015). One previous study found that adolescent exposure to MPH (2 mg/kg, i.p., 
twice a day for 16 days) significantly decreases the sucrose preference of adult rats for 
solutions ranging from 0.1 to 0.5% but not with a 1% sucrose concentration (Bolanos et 
al., 2003), while we used a 2% concentration (Fig. 1). On the other hand, other studies 
have reported unaltered sucrose preference (using 0.125% sucrose solution) in 
adulthood in singly-housed rats after adolescent chronic MPH administration (2-5 


































































mg/kg, once daily, i.p., 10 days), with sucrose preferences ranging between 59 and 72% 
(Crawford et al., 2013), in consistence with our own observations.  
 
When dorsal raphe nucleus serotonin neurons were recorded during adulthood, we did 
not see any change in the firing activity or in the total number of active neurons per 
track following chronic adolescent (early or late) MPH treatment (Table 1, Fig. 3). 
However, we found that an early adolescence exposure to MPH leads to increased burst 
activities of DRN serotonin neurons (Fig. 3B). In a similar way to dopamine neurons 
(Overton and Clark, 1997), bursting activity of DRN serotonin neurons is known to 
result in a greater efficiency of serotonin release in serotonin projecting region (Hajos 
and Sharp, 1996, Gartside et al., 2000, Hurtig et al., 2007, Hajos et al., 2007). Some 
serotonin neurons in the DRN may have adapted their firing mode following chronic 
MPH, by switching from single spike activities to bursting activities, without increasing 
their firing rates (Jennings, 2013), an effect that persists in time. Baseline burst levels in 
the control group, around 5%, was similar to previous findings (Manta et al., 2009, 
Schweimer and Ungless, 2010). The mechanism triggering burst activity in serotonin 
neurons is still poorly understood. Similarly to dopamine neurons, previous studies have 
found that SK channels (small conductance calcium-activated potassium channels) 
negatively control the firing pattern of 5-HT neurons (Rouchet et al., 2008). It is not 
known whether MPH administration has caused a down regulation of these ion 
channels. In addition, it will be necessary to examine other mechanisms that may also 
contribute to promote burst activity in serotonin neurons, such as the glutamatergic 
input via NMDA receptors, as observed in several other neuronal systems. One of the 
physiological significances of burst activity from DRN serotonin neurons may be to 
mediate the anticipation of reward, but not punishment. Indeed, during the anticipation 
period of a sucrose reward, mice displayed strong burst activity of DRN serotonin 
neurons, an effect not seen during the rewarding event itself (Cohen et al., 2015, Li et 
al., 2016).  
Interestingly, in our experiments, a strong negative linear correlation (r
2
 = 0.755) 
between sucrose preference and the burst activity of DRN serotonin neurons was 
observed in early adolescence MPH-treated animals (Fig. 3D). This may indicate a 
possible direct relationship between depression-like traits and the electrical activities of 


































































serotonin neurons. Anhedonia can reflect a state of stress which can disturb the reward 
system and cause these changes in firing pattern in some serotonin neurons which are 
“reward-sensitive”. In addition, it should be emphasized that serotonergic neurons in the 
DRN are not homogenous, with some groups being electrically responsive to stressor 
events (Crawford et al., 2010). More studies will be needed to characterise the exact 
relationship between depression-like traits in rodents and serotonin neuron electrical 
activities.  
 
We found that early but not late adolescence exposure to MPH induced a significant 
increase in sensitivity to D-amphetamine, assessed by an immediate but relatively short-
lasting increased number of rearing events induced by D-amphetamine (1 mg/kg, 
intraperitoneally). This was observed in adult animals previously exposed to MPH 
during early adolescence (Fig. 2), but not in adult rats exposed to MPH during late 
adolescence. Such effect may underlie plastic mechanisms that occurs following 
stimulant exposure during adolescence (Simchon Tenenbaum et al., 2015, Quansah et 
al., 2017). Though not totally understood, rearing activity can be considered as a good 
(but certainly not the only one) index of a motor response following drug administration 
(al-Khatib et al., 1995, El Yacoubi et al., 2000). Various agents, particularly dopamine 
releasing drugs, drive increases in both ambulation and rearing (Lever et al., 2006) 
which seems most likely related to striatal activities. This result stands in contrast to a 
previous study, where the authors found no relationship between adolescent exposure to 
MPH and sensitisation to methamphetamine in later life (Kuczenski and Segal, 2002). 
However, our study only focussed on rearing behaviour, which was only found to be 
increased in the first 15 minutes following the D-amphetamine administration. 
Furthermore, there was a difference in the dose administered and the route of 
administration of MPH during adolescence (gavage in Kuczenski study, which can 
induce stress and potentially confound experimental measurements). On the other hand, 
evidence of locomotor cross sensitisation exists in literature. Brandon et al (2001), 
using adolescent male Sprague-Dawley (SD) rats, demonstrated that pre-treatment with 
MPH may have a sensitising effect towards use of cocaine in adulthood, while also 
increasing self-administration of cocaine (Brandon et al., 2001). Other studies have also 
demonstrated locomotor sensitisation or cross-sensitisation, following a chronic i.p. 


































































MPH administration, whether in adult or adolescent animals (Yang et al., 2003, Yang et 
al., 2007, Yang et al., 2011). Nevertheless, our findings indicate a striking difference 
between early and late adolescent treated animals, indicating that utilisation of MPH 
during early adolescence may sensitise and/or predispose some sensitive subjects to 
later use of psychostimulant drugs, because important neural changes take place within 
the dopaminergic circuitry during this stage of development. However, in our study the 
effects observed are relatively mild and short-lasting, with inter-individual variation, 
indicating that, in clinical situation, only a fraction of subjects could be particularly 
vulnerable. In addition, these experiments were performed in healthy animals which 
prevent us to predict that ADHD patients will be equally sensitive. To note, however, it 
is widely admitted that psychostimulant drugs are sometimes not appropriately 
prescribed (Polanczyk et al., 2014). 
 
This behavioural observation stands in concordance with our electrophysiological data 
showing persistent alteration of dopamine electrophysiological activity caused by early 
adolescent MPH treatment, as shown by an increase in firing, burst and population 
activities (Fig. 4). Previous studies examining the effects of systemic treatment with 
MPH in adolescence found different results. According to Brandon (Brandon et al., 
2001) a short withdrawal following MPH exposure during adolescence (1 week, 2 
mg/kg i.p.) tends to increase both firing and burst activity, while long withdrawal 
(approximately the same period as in our study) significantly depressed firing activity 
(Brandon et al., 2003). There are differences in dose, route of administration, as well as 
period of treatment with our study. Such treatment may be too short and therefore not 
adequate to induce the persistent increase in dopamine neuronal activity that we have 
found. The i.p. administration may only induce a short-lasting peak of MPH in plasma, 
reducing the time by which the body is exposed to the drug. Oral administration is more 
likely to mimic the clinical situation, even if 5 mg/kg of oral MPH may look like a 
relatively high dose (though likely within therapeutic range, see Berridge et al., 2006 
and Thanos et al., 2015), it was given either continuously (overnight drinking water) or 
in two separate half doses (2.5 mg/kg), which likely prevent the occurrence of short 
lasting peak level of plasma MPH (Berridge et al., 2006, Thanos et al., 2015). It is also 
important to note that the use of the two slightly different procedures of oral 


































































administration (single dose intake or continuous administration) produced similar 
effects in our study. Other authors, Shen and Choong (2006) reported an increase in 
population activity after a short withdrawal which faded after long withdrawal, where a 
decrease in population activity was found in most animals (Shen and Choong, 2006). 
The authors attributed this fall in population activity to depolarisation-inactivation 
process, as population activity returned to normal following the administration of the 
dopamine D2 receptor agonist apomorphine. This effect was also observed by the same 
authors with other psychostimulants, such as amphetamine, cocaine, ethanol and 
nicotine (Choong and Shen, 2004). Depolarisation-inactivation is likely a consequence 
of excessive cell excitability. The change in excitability observed in our study obviously 
does not reach the extent of inducing a state of depolarisation-inactivation, like in Shen 
and Choong studies. Such changes in excitability may be caused by augmented 
glutamatergic neurotransmission onto VTA DA neurons, as has been suggested by 
others (Vanderschuren and Kalivas, 2000, Wanchoo et al., 2009, dela Pena et al., 2015, 
Creed et al., 2016). In partial agreement with our study, other authors have also found 
that adolescent amphetamine exposure, followed by a washout period, increased both 
dopamine and serotonin neuronal excitability, which was, however, only associated 
with increase in firing activity (Labonte et al., 2012). 
 
Interestingly, our data also demonstrated partial desensitisation of dopamine D2 
autoreceptors located on VTA dopamine neurons. When apomorphine, a potent, but not 
selective dopamine D2 receptor agonist, was given intravenously to adult rats previously 
exposed to chronic MPH during early adolescence, it produced a lower firing rate 
reduction than in control animals, proving a partial desensitisation of dopamine D2 
autoreceptors (Fig. 5). We repeated this observation with another more selective 
dopamine agonist (quinpirole) and compared the sensitivity of dopamine neurons in the 
early and late adolescent MPH-treated groups. We found a similar reduction of 
dopamine D2 receptor sensitivities, associated with a significantly smaller proportion of 
neurons that were completely inactivated by the agonist only in the early adolescent-
treated group (Fig. 6). Interestingly, in midbrain dopamine D2 receptor deficient mice 
(induced by conditional dopamine D2 receptor knockout), cocaine induced a stronger 
locomotor activity than in wild-type animals (Bello et al., 2011). One can wonder 


































































whether the partial desensitisation of the VTA dopamine D2 auto-receptors observed in 
our study can be associated to the greater locomotor response to D-amphetamine, at 
least in the initial phase of the challenge. A partial reduction of autoreceptor sensitivity 
will attenuate negative feedback mechanism on dopamine cells, preventing the neuron 
to reduce its electrical activity following VTA dopamine overflow caused by the 
releasing agent, leading to more dopamine release in terminal area. We therefore 
hypothesised that chronic MPH treatment during early adolescence may induce 
persistent changes in dopamine D2 receptor sensitivity. As discussed before, whether 
this can then translate into increased sensitivities to addictive drugs is still an open 
question. Interestingly, higher electrical activity of dopamine neurons and lower 
sensitivity to D2 agonist has also been associated to enhanced vulnerability to cocaine 
self-administration (Marinelli and White, 2000). In ADHD patients, dopamine 
neurotransmission is disturbed, and the persistent changes we observed may not have 
the same effect than in healthy individuals. For instance, dopamine D2 receptor 
density/sensitivity may be increased in ADHD (Cho et al., 2014), as a consequence of 
increased levels of dopamine transporter and reduced synaptic dopamine concentration 
(Fusar-Poli et al., 2012). Our study may indicate that such disturbance can be amended 
after chronic MPH administration. 
Interestingly, in rodents, diet-induced obesity caused lower VTA dopamine-D2 
autoreceptor sensitivity (Koyama et al., 2014) and higher D-amphetamine induced 
activity (Naneix et al., 2017). It would be particularly important to examine whether this 
partial desensitisation observed in our study is only observable on the dopamine 
autoreceptors found in the VTA, or if such a desensitisation can also affect another 
population of dopamine D2 receptors, such as the postsynaptic D2 autoreceptors found 
in striatal medium spiny neurons. 
 
In conclusion, we have demonstrated that adolescent exposure to MPH, followed by 
drug withdrawal, does not induce delayed growth or anhedonia-like behaviour. 
However, exposure to chronic MPH during early adolescence affects the electrical 
functions of DRN serotonin and VTA dopamine neurons. Dopaminergic neurons 
display higher level of electrical activity which may be associated to both a partial 
dopamine D2 autoreceptor desensitisation. It also appeared that early adolescence oral 


































































exposure to MPH can increase sensitisation to later D-amphetamine administration in 
adulthood. To our knowledge, we describe here for the first time the differences 
between early and late adolescence exposure to methylphenidate. Moreover, our 
protocol was chosen to best mimic clinical situations, using similar doses, routes of 
administration and length of treatment. In this regard, it is worth mentioning that in our 
study, single oral dose intake or continuous administration, comparable to some extents 
to immediate and to extended release, caused similar long-term effects. It is of course 
not possible to claim from our data that MPH treatment can put all patients at risk for 
drug abuse during later life. It may be on the contrary that these persistent effects help 
to restore a deficient dopaminergic system and contribute to prevent the reoccurrence of 
the ADHD symptoms in adulthood. On the other hand, if administered to a healthy child 
who has inappropriately been diagnosed with ADHD, our data indicates that 
administering the drug may induce persistent changes on dopamine-dependent 
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Table 1: Electrophysiological characteristics of dopamine neurons and 
serotonergic neurons according to periods of treatment and administration routes. 
**p<0.01, vs. corresponding vehicle-treated animals; *p<0.03, vs. naive or 
corresponding vehicle-treated animals, #p<0.03, vs. corresponding early adolescence-
treated animals, unpaired Student’s t-test; n indicates the number of cells recorded from 
4-9 rats per subgroup. 
 
 
Figure 1: Chronic adolescent exposure to methylphenidate and sucrose preference 
at adulthood. 
(A): Control animals and MPH-treated animals from both groups (late and early 
adolescence) successfully learned to discriminate ater from sucrose, assessed by a 
drastic increase of volume intake from day 1 to day 2, corresponding to the transition 
between water and sucrose. Average volume intakes (water or sucrose) are not different 
between control and MPH treated animals in the two groups during the entire 
experimental protocol. Note that the late adolescence group tends to drink more fluid 
because the animals were significantly bigger. (B): Animals from both groups (early 
and late adolescence) showed similar sucrose preference scores (expressed as the 
quotient of sucrose consumption to the total liquid intake over each day). (C): Average 
sucrose preference scores over the test period (Day 2-4). Note that 1 animal out of 4 in 
controls, and 2 treated animals out of 8 from the early adolescence-treated groups 


































































displayed low sucrose preference (score below 65%, dashed line). Late adolescence 
treated animals show similar profile of sucrose preferences as related controls and as 
early adolescence treated animals, but with less scattered values. (D): To confirm if any 
anhedonic-like behaviour was naturally occurring in our batch of animals, 10 naive 
animals were also scored for sucrose preference at the same age as the adolescent-
treated animals. We observed that 10% of all animals (1/10) could be considered as 
displaying anhedonic-like behaviour (score below 65%).    
 
Figure 2: Early adolescence exposure to methylphenidate induces changes in 
rearing activity to later D-amphetamine challenge. 
During the first 15 minutes of observation following D-amphetamine (1 mg/kg, 
intraperitoneally) challenges, MPH-treated animals during early adolescence displayed 
significantly greater rearing events than control animals. On the other hand, adult rats 
previously treated with MPH during late adolescence did not display any significant 
increase in rearing activity during the initial part of the challenge.  
*p<0.03 vs. vehicle and MPH late adolescence, Student’s t-test; n indicates the number 
of rats tested.  
 
 
Figure 3: Electrophysiological characteristics of dorsal raphe nucleus serotonin 
neurons following chronic MPH exposure and correlation to sucrose preference. 
(A, B, C): Chronic MPH treatment during early adolescence, but not late adolescence, 
increased the burst activities of dorsal raphe nucleus (DRN) serotonin neurons at 
adulthood, without significantly changing the firing rates nor the total number of active 
neurons per electrode descent. **p<0.01 vs. controls; Newman-Keuls test after 
significant one-way ANOVA; n indicates the number of neurons tested (A, B) or 
electrode descents (C), from 8-15 animals per group. (D): In early adolescence MPH-
treated animals, but not in the other groups, a strong correlation was found between the 
bursting activities of DRN neurons and sucrose preference scores, but not with cell 
firing activities nor the total number of active neurons (not shown), showing that high 
burst activities are correlated to low sucrose preference scores. r
2
 value indicates the 
correlation coefficient. (E, G): Representative firing examples of two serotonergic 


































































neurons displaying burst activities, each recorded from a MPH-treated animal. The 
arrows represent the magnified position chosen in F and H. (F, H): Burst events, 
consisting of doublets of spikes in short intervals.  
 
 
Figure 4: Electrophysiological characteristics of ventral tegmental area dopamine 
neurons following chronic MPH exposure. 
Chronic treatments with MPH (5 mg/kg/day) during late adolescence did not alter firing 
rate (A), burst activities (B) or total number of spontaneously active dopaminergic 
neurons per electrode descent (C). However, chronic exposure to MPH during early 
adolescence significantly increased firing, burst, and population activities of midbrain 
dopamine neurons measured at adulthood. **p<0.01 vs. controls and adult-treated; 
*p<0.05 and **p<0.01 vs. controls; Newman-Keuls test after significant one-way 
ANOVA; n indicates the number of neurons tested (A, B) or electrode descents (C), 




Figure 5: Early adolescent exposure to chronic methylphenidate induces partial 
desensitisation of dopamine neurons to apomorphine in adulthood. 
(A): MPH-treated animals during early adolescence displayed significantly lower firing 
rate reductions following progressive apomorphine challenges, administered in a dose-
response manner and with progressive 10 µg/kg increments. *p<0.05 vs. controls, 
Bonferroni after significant repeated measures two-way ANOVA. Note that eticlopride 
successfully reversed apomorphine-induced firing rate reductions. (B): Compared to 
controls, animals previously exposed to chronic MPH in early adolescence had 
significantly lower sensitivities to dopamine D2 receptor agonism (F1,8=12.57, p<0.01). 
n indicates the number of neurons/rats tested. *p<0.05 vs controls, Bonferroni after 
significant repeated measures two-way ANOVA. (C): Representative firing example of 
a dopaminergic neuron from an early adolescence MPH-treated animals displaying burst 
activities, together with a weak sensitivity to cumulative apomorphine administration. 


































































The two bottom arrows represent the magnified position chosen in D. (D): Burst event, 
consisting of a triplet of spikes.  
 
 
Figure 6: Early but not late adolescence exposure to chronic methylphenidate 
partially induces desensitisation of dopamine neurons to the D2 agonist quinpirole 
in adulthood. 
(A): Intravenous challenges with quinpirole (20 µg/kg, another D2 receptor agonist) 
significantly reduced the firing activities of VTA dopamine neurons in both control and 
MPH-treated animals (p<0.0001). Eticlopride (0.2 mg/kg) successfully recovered such 
firing rate reductions. (B): Methylphenidate-treated animals during early adolescence 
but not during late adolescence presented a lower sensitivity to quinpirole challenges in 
adulthood. *p<0.05, compared to control and adult-treated rats, Newman-Keul test after 
significant ANOVA; n indicates the number of neurons/rats tested. 
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Figure 2: Early adolescence exposure to methylphenidate induces changes in rearing activity to later D-amphetamine challenge. 
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Figure 4: Electrophysiological characteristics of ventral tegmental area dopamine neurons following chronic MPH exposure. 





















































































0 10 20 30 40 50 
Eticlopride 
0.2 mg/kg 
Apomorphine i.v. doses 
(µg/kg) 
Controls, n=7 MPH early adolescence, n=7 
Apomorphine 
(µg/kg) 




































































































































































Saline 0.2 ml/kg 
Quinpirole 20 µg/kg 
+ + 
+ 



























MPH early adolescence, n=7 
MPH late adolescence, n=7 
Controls, n=12 
MPH early adolescence, n=7 




































Figure 6:  Early but not late adolescence exposure to chronic methylphenidate partially induces desensitisation of dopamine neurons to the 
D2 agonist quinpirole in adulthood. 
 



















































































MPH 14.5 ±1.9 14.7 ± 4.1** 50 





MPH 12.0 ± 1.1 8.6 ± 2.0 79 





Drinking water MPH 38.5 ± 2.6 42.5 ± 3.7* 45 
Sucrose 
solution 
MPH 39.3 ± 3.8 31.4 ± 5.4 24 
Vehicles 34.3 ± 3.8 26.5 ± 4.8 29 
Late-
Adolescence 
Drinking water MPH 33.4 ± 5.2 26.7 ± 5.2 # 15 
Sucrose 
solution 
MPH 26.5  ± 2.0 20.2 ± 2.9 74 
Vehicles 28.0 ± 1.8 20.2 ± 2.7 68 
Naive 
n/a (water ad 
libitum) 
Untreated 31.8 ± 3.9 28.7 ± 3.1 30 
Table 1: Electrophysiological characteristics of dopamine neurons and serotonergic neurons according to periods of treatment and 
administration routes. 
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